BSN repricing to draw on US heat

EQT-owned German bandage maker BSN Medical (B/B2) is looking to reprice its €740m term loan ‘B’ at tighter terms just three months after signing, with leveraged finance bankers confident that the strength of the US loan market would make the adjustment possible.

  • 02 Oct 2012

BSN is looking to reduce the margin on the €455m euro-denominated tranche from 500bp to 425bp, and cut the margin on its €225m-equivalent US dollar tranche from 475bp to 325bp. The euro loans are offered at 99.5, with the dollar loans at par.

The Libor floors will remain at ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 BNP Paribas 14,443 29 18.07
2 Bank of America Merrill Lynch (BAML) 8,264 27 10.34
3 Lloyds Bank 7,329 24 9.17
4 Citi 6,748 19 8.44
5 JP Morgan 5,220 8 6.53

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 117,261.12 337 11.09%
2 Bank of America Merrill Lynch 94,721.79 272 8.96%
3 JPMorgan 92,612.23 269 8.76%
4 Wells Fargo Securities 82,597.19 239 7.81%
5 Credit Suisse 69,442.99 183 6.57%